Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Therapeutic Innovation & Regulatory Science
|
January 3, 2024
Pediatric Market Access: A Qualitative Study
Lieke Maas, Angelika Joos, Mickael Hiligsmann
International Journal of Technology Assessment in Health Care
|
September 25, 2018
EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION
Lina Balaisyte, Angelika Joos, Mickaël Hiligsmann
European Journal of Pediatrics
|
September 21, 2016
Moving toward a paradigm shift in the regulatory requirements for pediatric medicines
William Wei Lim Chin, Angelika Joos
International Journal of Technology Assessment in Health Care
|
February 24, 2021
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements
Hannah Sievers, Angelika Joos, Mickaël Hiligsmann
Frontiers in Medicine
|
September 21, 2023
What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements
Nevena Miletic, Sarah Adam, Jacqueline Acquah, et al.
Journal of Global Antimicrobial Resistance
|
February 16, 2022
Discrete choice experiment to investigate preferences for incentives to promote antimicrobial research and development
Leon Rohde, Elias Mossialos, Charlotte Beaudart, et al.
Clinical Therapeutics
|
November 10, 2019
Orphan Medicines for Pediatric Use: A Focus on the European Union
Winona Rei Bolislis, Solange Corriol-Rohou, Claire Hill-Venning, et al.
Therapeutic Innovation & Regulatory Science
|
November 6, 2015
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
Anton Hoos, James Anderson, Marc Boutin, et al.
Clinical Pharmacology and Therapeutics
|
January 7, 2021
Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches
Winona Rei Bolislis, Gesine Bejeuhr, Fawzi Benzaghou, et al.
Journal of Pharmaceutical Sciences
|
September 12, 2014
Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test
Joerg H O Garbe, Susanne Ausborn, Claire Beggs, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Therapeutic Innovation & Regulatory Science
|
January 3, 2024
Pediatric Market Access: A Qualitative Study
Lieke Maas, Angelika Joos, Mickael Hiligsmann
International Journal of Technology Assessment in Health Care
|
September 25, 2018
EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION
Lina Balaisyte, Angelika Joos, Mickaël Hiligsmann
European Journal of Pediatrics
|
September 21, 2016
Moving toward a paradigm shift in the regulatory requirements for pediatric medicines
William Wei Lim Chin, Angelika Joos
International Journal of Technology Assessment in Health Care
|
February 24, 2021
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements
Hannah Sievers, Angelika Joos, Mickaël Hiligsmann
Frontiers in Medicine
|
September 21, 2023
What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements
Nevena Miletic, Sarah Adam, Jacqueline Acquah, et al.
Journal of Global Antimicrobial Resistance
|
February 16, 2022
Discrete choice experiment to investigate preferences for incentives to promote antimicrobial research and development
Leon Rohde, Elias Mossialos, Charlotte Beaudart, et al.
Clinical Therapeutics
|
November 10, 2019
Orphan Medicines for Pediatric Use: A Focus on the European Union
Winona Rei Bolislis, Solange Corriol-Rohou, Claire Hill-Venning, et al.
Therapeutic Innovation & Regulatory Science
|
November 6, 2015
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
Anton Hoos, James Anderson, Marc Boutin, et al.
Clinical Pharmacology and Therapeutics
|
January 7, 2021
Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches
Winona Rei Bolislis, Gesine Bejeuhr, Fawzi Benzaghou, et al.
Journal of Pharmaceutical Sciences
|
September 12, 2014
Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test
Joerg H O Garbe, Susanne Ausborn, Claire Beggs, et al.
Page
of 2